Metabolic Dysfunction-Associated Steatotic Liver Disease
Prevalence, research insights and the future directions
- Publisher's listprice EUR 160.49
-
68 079 Ft (64 837 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 8% (cc. 5 446 Ft off)
- Discounted price 62 633 Ft (59 650 Ft + 5% VAT)
68 079 Ft
Availability
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 2025
- Publisher Springer
- Date of Publication 31 December 2024
- Number of Volumes 1 pieces, Book
- ISBN 9789819795185
- Binding Hardback
- No. of pages170 pages
- Size 254x178 mm
- Language English
- Illustrations 1 Illustrations, black & white; 25 Illustrations, color 675
Categories
Short description:
This book provides crucial insights into the most recent advancements in understanding pathophysiology of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), and presents innovative treatment approaches. The emerging areas of study and potential avenues for further investigation are discussed in chapters. Additionally, the latest information on diagnostic tools, lifestyle interventions, and pharmacological treatments is also presented. With the worldwide prevalence of MASLD on the rise, it helps to equip medical professionals (hepatologists, gastroenterologists, endocrinologists, cardiologists, nephrologists, internists, and surgeons), researchers, and patients with up-to-date knowledge to effectively combat this multifaceted condition.
MoreLong description:
This book provides crucial insights into the most recent advancements in understanding pathophysiology of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), and presents innovative treatment approaches. The emerging areas of study and potential avenues for further investigation are discussed in chapters. Additionally, the latest information on diagnostic tools, lifestyle interventions, and pharmacological treatments is also presented. With the worldwide prevalence of MASLD on the rise, it helps to equip medical professionals (hepatologists, gastroenterologists, endocrinologists, cardiologists, nephrologists, internists, and surgeons), researchers, and patients with up-to-date knowledge to effectively combat this multifaceted condition.
MoreTable of Contents:
.- Chapter 1 Introduction of MAFLD/MASLD.
.- Chapter 2 UNVEILING THE MAFLD/MASLD EPIDEMIC.
.- Chapter 3 Decoding MAFLD?s pathophysiology.
.- Chapter 4 Liver Steatosis: From Lipotoxicity to Cellular Damage.
.- Chapter 5 Diagnostic Advances in MAFLD/MASLD.
.- Chapter 6 Histopathology of MAFLD/MASLD: insights into liver tissue changes.
.- Chapter 7 MAFLD as a multisystemic disease.
.- Chapter 8 MASLD and Hepatic/Extrahepatic Cancers Understanding the Complex Relationship.
.- Chapter 9 Current Standards in Therapeutic Management.
.- Chapter 10 REVOLUTIONARY BREAKTHROUGHS.
.- Chapter 11 Integrative Approaches to MAFLD/MASLD Management.
.- Chapter 12 MAFLD/MASLD IN SPECIAL POPULATIONS.
.- Chapter 13 Looking ahead.
.- Chapter 14 METABOLIC STEATOHEPATITIS AFTER LIVER TRANSPLANTATION.
More
Metabolic Dysfunction-Associated Steatotic Liver Disease: Prevalence, research insights and the future directions
Subcribe now and receive a favourable price.
Subscribe
68 079 HUF
